FIELD: medicine.
SUBSTANCE: method provides using a solid phase of an influenza virus vaccine for sensitisation, whereas antigen-antibody complexes formed by incubating the sensitised surface of an immunosorbent with a test serum containing the influenza virus antibodies are visualised by means of an optical contrast carbon-protein G conjugate for 10-15 minutes.
EFFECT: producing simple, high-sensitive, operative, clear and reliable diagnostic system for estimating a level of post-vaccine immunity to the influenza virus.
1 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ESTIMATION OF EFFECIENCY OF VACCINATION AGAINST PERTUSSIS, DIPHTHERIA AND TETANUS | 2016 |
|
RU2626679C1 |
INSTRUMENT-FREE DIAGNOSTIC TECHNIQUE FOR PSEUDOTUBERCULOSIS | 2011 |
|
RU2464573C1 |
VACCINE AGAINST INFLUENZA VIRUS AND METHOD OF ITS PREPARING | 2000 |
|
RU2164148C1 |
METHOD FOR PREVENTING INFLUENZA BY COMBINED APPLICATION OF INTERFERON GAMMA AND INACTIVATED ANTI-INFLUENZA VACCINE | 2011 |
|
RU2546540C2 |
CROSS-REACTIVE RECOMBINANT HUMAN INFLUENZA A VIRUS VACCINE | 2020 |
|
RU2742336C1 |
IMMUNOENZYMOMETRIC TEST SYSTEM FOR SEROLOGIC DIAGNOSIS OF REOVIRUS INFECTION IN CATTLE AND MONITORING OF POST-VACCINATION IMMUNITY LEVEL | 2011 |
|
RU2488117C2 |
DIAGNOSTIC SET FOR DETECTING ANTIBODIES TO AVIAN INFLUENZA VIRUS SUBTYPE H9 IN HEMAGGLUTINATION INHIBITION REACTION | 2020 |
|
RU2738900C1 |
INFLUENZA VACCINE AND METHOD FOR PREPARING IT | 2010 |
|
RU2446824C2 |
MODIFIED INFLUENZA VIRUS FOR MONITORING AND INCREASING VACCINE EFFICACY | 2006 |
|
RU2420535C2 |
METHOD FOR PROPHILAXIS OF INFLUENZA | 0 |
|
SU731971A1 |
Authors
Dates
2014-11-20—Published
2013-07-23—Filed